ClinicalTrials.Veeva

Menu

Exploratory Study on Two Different Doses of VML-0001 on the Effects on Vaginal pH in Healthy Post-Menopausal Women

V

Viramal

Status

Completed

Conditions

Vaginal Atrophy

Treatments

Device: VML-0001

Study type

Observational

Funder types

Industry

Identifiers

NCT03770065
VML-0001-003

Details and patient eligibility

About

The study is designed to determine the effect on vaginal pH and the duration of action measured on the ability of the base formulation to reduce the vaginal pH

Enrollment

14 patients

Sex

Female

Ages

45+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • be greater than 45 years
  • no positive findings on screening gynaecological examination
  • negative smear test within the last 5 years

Exclusion criteria

  • has signs of vaginal infection
  • has evidence of alcohol abuse
  • has used hormonal replacement therapy in three months prior to study entry

Trial design

14 participants in 2 patient groups

Group A
Treatment:
Device: VML-0001
Group B
Treatment:
Device: VML-0001

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems